oasis-1 oral semaglutide 50 mg obesity nejm 2023 Obesity: once-daily GLP-1 orforglipron shows clinically meaningful weight loss Oral Semaglutide and Cardiovascular Outcomes

Its also possible the side effects wont manifest at all in humans

Acetylcarnitine levels in cells can directly affect the acetylation of certain genes and thus regulate cellular function when fatty acid oxidation is high.[ref] MicroRNAs are short strands of RNA that attach to mRNA and regulate how much of a protein is expressed

Cardiovascular Health: B12 works with other B vitamins to lower homocysteine, an amino acid that, at high levels, increases the risk of heart disease

Can InBody replace DEXA scans for GLP-1 monitoring

Small changes added up over time, and I feel stronger, more focused, and encouraged to continue